## RKLB: Rocket Lab Corporation - XLI: Industrials

### Executive Summary

PARABOLIC warning: MRS_10 at 6.4% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops. MRS_5 (7.1%) even more extended - blow-off risk elevated.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($65.23)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Rocket Lab Hits Record $600M Revenue in 2025 but Delays Neutron Maiden Flight to 2026**
- Source: FinancialContent | 20251231T100400 | Somewhat-Bullish | Relevance: 100%
- Rocket Lab USA, Inc. reported record-breaking annual revenue approaching $600 million for fiscal year 2025, driven by a 100% success rate across 21 Electron missions and robust Space Systems growth. However, the maiden flight of its Neutron medium-lift rocket has been delayed to mid-2026 due to extended qualification for its Archimedes engine. Despite short-term market volatility, a $1.1 billion contract backlog and a strategic pivot towards high-margin satellite manufacturing provide a strong financial foundation and long-term optimism for the company.

**2. Rocket Labâ€™s Defense Contract Fuels Investor Optimism Amid Launch Delays**
- Source: AD HOC NEWS | 20260102T064204 | Somewhat-Bullish | Relevance: 100%
- Rocket Lab USA is experiencing investor optimism due to an $816 million defense contract from the Space Development Agency, which pivots the company further into satellite manufacturing and national security. This positive development comes even as its crucial Neutron rocket program faces launch delays. Investors are weighing the company's strong revenue growth against persistent profitability challenges and notable insider selling activity.

**3. Rocket Lab USA Stock (RKLB) Opinions on $816 Million SDA Contract**
- Source: Quiver Quantitative | 20260101T173300 | Somewhat-Bullish | Relevance: 100%
- Social media chatter is largely positive regarding Rocket Lab USA's recent $816 million contract with the U.S. Space Development Agency, which is seen as a significant win for the company. Despite caution around the Neutron rocket's delayed maiden flight, investors are optimistic about the company's 175% stock surge in 2025 and record revenue of $600 million. Insider trading activity, institutional holdings, government contracts, and analyst ratings are also contributing to the dynamic market sentiment around RKLB.

**4. Rocket Lab Stock: Balancing Major Contracts Against Valuation Concerns**
- Source: AD HOC NEWS | 20251231T065105 | Somewhat-Bullish | Relevance: 100%
- Rocket Lab USA's stock has stalled after a significant 175% surge in 2025, facing turbulence from a record peak. This comes amidst conflicting signals including a major $816 million defense contract for 18 satellites, and insider selling activity combined with ongoing profitability concerns. Analysts have raised price targets due to the defense contract, but investors are advised to monitor the Neutron rocket development and satellite production schedule for sustained cash flow.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Needham | $90 | $63 | +43% |
| 2025-12-22 | Stifel | $85 | $75 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Needham | main | Buy |
| 2025-12-22 | Stifel | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 16 ($25.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.8% (+5.4%)
- Blackrock Inc.: 5.9% (+38.0%)
- Capital World Invest: 2.7% (+9.4%)
- State Street Corpora: 2.3% (+13.6%)
- BAILLIE GIFFORD & CO: 2.3% (+176.1%)

### Key Risks

1. High beta (2.21) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $26M sold (16 transactions in 90 days).
3. Elevated short interest (8.7%): bears positioning against stock.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.45 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 47% YoY. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($25.5M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.6B |
| Beta | 2.21 |
| 52W Range | $14.71 - $79.83 |
| Short Interest | 8.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.45 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 improving modestly (+0.6% over 5 days). Extended beyond STRENGTH zone (6.4% > 6.0%), caution on chasing. MRS_5 at 7.1% confirms short-term momentum alignment. Outperforming sector by 4.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.88), confirming momentum. OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 6.37% (CS: 97) | Strong |
| RSI_14 | 67.6 | Neutral |
| MACD Histogram | 0.88 | Bullish |
| vs SMA20 | 1.197x | Above |
| vs SMA50 | 1.355x | Above |
| vs SMA200 | 1.823x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $75.99
- **Stop Loss:** $65.23 (14.2% risk)
- **Target:** $86.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 133
- **Position Value:** $10,106.67
- **Portfolio %:** 10.11%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.10 | $-0.03 | +71.3% |
| 2025Q2 | $-0.11 | $-0.13 | -17.9% |
| 2025Q1 | $-0.12 | $-0.12 | +0.5% |
| 2024Q4 | $-0.10 | $-0.10 | -2.2% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*